γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis

Cellular Immunology

Volumn 290, Issue 1, 2014, Pages 39-51

  Blink, Sarah E ^a   Caldis, Matthew W ^a   Goings, Gwendolyn E ^a   Harp, Christopher T ^a   Malissen, Bernard ^c   Prinz, Immo ^b   Xu, Dan ^a   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

Adaptive immunity; Autoimmunity; Experimental autoimmune encephalomyelitis; Innate immunity; Multiple sclerosis; T cells; T cells

Indexed keywords

CHEMOKINE RECEPTOR CCR5; INTERLEUKIN 17; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SELECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; IMMUNOFLUORESCENCE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; TISSUE SPECIFICITY;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INNATE IMMUNITY; MULTIPLE SCLEROSIS; T CELLS; ΓΔ T CELLS;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; DOWN-REGULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, CCR5; TH17 CELLS;

EID: 84901296475     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.04.013     Document Type: Article

References (66)

1. Steinman L., Martin R., Bernard C., Conlon P., Oksenberg J.R. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci. 2002, 25:491-505.
2. Smith C.E., Miller S.D. Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities. J. Autoimmun. 2006, 27:218-231.
3. Ferber I.A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., Fathman C.G. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 1996, 156:5-7.
4. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
5. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
6. Martin B., Hirota K., Cua D.J., Stockinger B., Veldhoen M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009, 31:321-330.
7. Sutton C.E., Lalor S.J., Sweeney C.M., Brereton C.F., Lavelle E.C., Mills K.H. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009, 31:331-341.
8. Stark M.A., Huo Y., Burcin T.L., Morris M.A., Olson T.S., Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005, 22:285-294.
9. Roark C.L., French J.D., Taylor M.A., Bendele A.M., Born W.K., O'Brien R.L. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells. J. Immunol. 2007, 179:5576-5583.
10. Murdoch J.R., Lloyd C.M. Resolution of allergic airway inflammation and airway hyperreactivity is mediated by IL-17 Producing gamma-delta T Cells. Am. J. Respir. Crit. Care Med. 2010, 182:464-476.
11. Shichita T., Sugiyama Y., Ooboshi H., Sugimori H., Nakagawa R., Takada I., Iwaki T., Okada Y., Iida M., Cua D.J., Iwakura Y., Yoshimura A. Pivotal role of cerebral interleukin-17-producing gammadelta T cells in the delayed phase of ischemic brain injury. Nat. Med. 2009, 15:946-950.
12. Wucherpfennig K.W., Newcombe J., Li H., Keddy C., Cuzner M.L., Hafler D.A. Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:4588-4592.
13. Sobel R.A., Kuchroo V.K. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions. J. Immunol. 1992, 149:1444-1451.
14. Haregewoin A., Soman G., Hom R.C., Finberg R.W. Human gamma delta+ T cells respond to mycobacterial heat-shock protein. Nature 1989, 340:309-312.
15. Blink S.E., Miller S.D. The contribution of gammadelta T cells to the pathogenesis of EAE and MS. Curr. Mol. Med. 2009, 9:15-22.
16. Ponomarev E.D., Novikova M., Yassai M., Szczepanik M., Gorski J., Dittel B.N. Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis. J. Immunol. 2004, 173:1587-1595.
17. Ponomarev E.D., Dittel B.N. Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism. J. Immunol. 2005, 174:4678-4687.
18. Olivares-Villagomez D., Wang Y., Lafaille J.J. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J. Exp. Med. 1998, 188:1883-1894.
19. Petermann F., Rothhammer V., Claussen M.C., Haas J.D., Blanco L.R., Heink S., Prinz I., Hemmer B., Kuchroo V.K., Oukka M., Korn T. Gamma delta T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 2010, 33:351-363.
20. Clark R.B., Lingenheld E.G. Adoptively transferred EAE in gamma delta T cell-knockout mice. J. Autoimmun. 1998, 11:105-110.
21. Rajan A.J., Klein J.D., Brosnan C.F. The effect of gammadelta T cell depletion on cytokine gene expression in experimental allergic encephalomyelitis. J. Immunol. 1998, 160:5955-5962.
22. Odyniec A., Szczepanik M., Mycko M.P., Stasiolek M., Raine C.S., Selmaj K.W. Gammadelta T cells enhance the expression of experimental autoimmune encephalomyelitis by promoting antigen presentation and IL-12 production. J. Immunol. 2004, 173:682-694.
23. Cardona A.E., Teale J.M. Gamma/delta T cell-deficient mice exhibit reduced disease severity and decreased inflammatory response in the brain in murine neurocysticercosis. J. Immunol. 2002, 169:3163-3171.
24. Rajan A.J., Gao Y.L., Raine C.S., Brosnan C.F. A pathogenic role for gamma delta T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse. J. Immunol. 1996, 157:941-949.
25. Spahn T.W., Issazadah S., Salvin A.J., Weiner H.L. Decreased severity of myelin oligodendrocyte glycoprotein peptide 33-35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene. Eur. J. Immunol. 1999, 29:4060-4071.
26. Prinz I., Sansoni A., Kissenpfennig A., Ardouin L., Malissen M., Malissen B. Visualization of the earliest steps of gammadelta T cell development in the adult thymus. Nat. Immunol. 2006, 7:995-1003.
27. Hahn Y.S., Taube C., Jin N., Sharp L., Wands J.M., Aydintug M.K., Lahn M., Huber S.A., O'Brien R.L., Gelfand E.W., Born W.K. Different potentials of gamma delta T cell subsets in regulating airway responsiveness: V gamma 1+ cells, but not V gamma 4+ cells, promote airway hyperreactivity, Th2 cytokines, and airway inflammation. J. Immunol. 2004, 172:2894-2902.
28. O'Brien R.L., Happ M.P., Dallas A., Palmer E., Kubo R., Born W.K. Stimulation of a major subset of lymphocytes expressing T cell receptor gamma delta by an antigen derived from Mycobacterium tuberculosis. Cell 1989, 57:667-674.
29. Allison J.P., Havran W.L. The immunobiology of T cells with invariant gamma delta antigen receptors. Annu. Rev. Immunol. 1991, 9:679-705.
30. O'Brien R.L., Roark C.L., Jin N., Aydintug M.K., French J.D., Chain J.L., Wands J.M., Johnston M., Born W.K. Gammadelta T-cell receptors: functional correlations. Immunol. Rev. 2007, 215:77-88.
31. Koenecke C., Chennupati V., Schmitz S., Malissen B., Forster R., Prinz I. In vivo application of mAb directed against the gammadelta TCR does not deplete but generates "invisible" gammadelta T cells. Eur. J. Immunol. 2009, 39:372-379.
32. Valitutti S., Muller S., Cella M., Padovan E., Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995, 375:148-151.
33. Bachmann M.F., Oxenius A., Speiser D.E., Mariathasan S., Hengartner H., Zinkernagel R.M., Ohashi P.S. Peptide-induced T cell receptor down-regulation on naive T cells predicts agonist/partial agonist properties and strictly correlates with T cell activation. Eur. J. Immunol. 1997, 27:2195-2203.
34. Itoh Y., Hemmer B., Martin R., Germain R.N. Serial TCR engagement and down-modulation by peptide: MHC molecule ligands: relationship to the quality of individual TCR signaling events. J. Immunol. 1999, 162:2073-2080.
35. Cui Y., Shao H., Lan C., Nian H., O'Brien R.L., Born W.K., Kaplan H.J., Sun D. Major role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells. J. Immunol. 2009, 183:560-567.
36. Lockhart E., Green A.M., Flynn J.L. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 2006, 177:4662-4669.
37. Turner J.E., Krebs C., Tittel A.P., Paust H.J., Meyer-Schwesinger C., Bennstein S.B., Steinmetz O.M., Prinz I., Magnus T., Korn T., Stahl R.A., Kurts C., Panzer U. IL-17A production by renal gammadelta t cells promotes kidney injury in crescentic GN. J. Am. Soc. Nephrol. 2012, 23:486-495.
38. Narayan K., Sylvia K.E., Malhotra N., Yin C.C., Martens G., Vallerskog T., Kornfeld H., Xiong N., Cohen N.R., Brenner M.B., Berg L.J., Kang J. Intrathymic programming of effector fates in three molecularly distinct gammadelta T cell subtypes. Nat. Immunol. 2012, 13:511-518.
39. Freedman M.S., Ruijs T.C., Selin L.K., Antel J.P. Peripheral blood gamma-delta T cells lyse fresh human brain-derived oligodendrocytes. Annu. Neurol. 1991, 30:794-800.
40. Lin W., Bailey S.L., Ho H., Harding H.P., Ron D., Miller S.D., Popko B. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J. Clin. Invest. 2007, 117:448-456.
41. Kroetz D.N., Deepe G.S. CCR5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T cells in fungal infection. J. Immunol. 2010, 184:5224-5231.
42. Kobayashi Y., Kawai K., Ito K., Honda H., Sobue G., Yoshikai Y. Aggravation of murine experimental allergic encephalomyelitis by administration of T-cell receptor gammadelta-specific antibody. J. Neuroimmunol. 1997, 73:169-174.
43. Wohler J.E., Smith S.S., Zinn K.R., Bullard D.C., Barnum S.R. Gammadelta T cells in EAE: early trafficking events and cytokine requirements. Eur. J. Immunol. 2009, 39:1516-1526.
44. Huber S.A., Graveline D., Born W.K., O'Brien R.L. Cytokine production by Vgamma(+)-T-cell subsets is an important factor determining CD4(+)-Th-cell phenotype and susceptibility of BALB/c mice to coxsackievirus B3-induced myocarditis. J. Virol. 2001, 75:5860-5869.
45. Huang Y., Jin N., Roark C.L., Aydintug M.K., Wands J.M., Huang H., O'Brien R.L., Born W.K. The influence of IgE-enhancing and IgE-suppressive gammadelta T cells changes with exposure to inhaled ovalbumin. J. Immunol. 2009, 183:849-855.
46. Kress E., Hedges J.F., Jutila M.A. Distinct gene expression in human Vdelta1 and Vdelta2 gammadelta T cells following non-TCR agonist stimulation. Mol. Immunol. 2006, 43:2002-2011.
47. Kim H.R., Cho M.L., Kim K.W., Juhn J.Y., Hwang S.Y., Yoon C.H., Park S.H., Lee S.H., Kim H.Y. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways. Rheumatology (Oxford, England) 2007, 46:57-64.
48. Tzartos J.S., Friese M.A., Craner M.J., Palace J., Newcombe J., Esiri M.M., Fugger L. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 2008, 172:146-155.
49. Fossiez F., Djossou O., Chomarat P., Flores-Romo L., Ait-Yahia S., Maat C., Pin J.J., Garrone P., Garcia E., Saeland S., Blanchard D., Gaillard C., Das Mahapatra B., Rouvier E., Golstein P., Banchereau J., Lebecque S. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 1996, 183:2593-2603.
50. Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., Giuliani F., Arbour N., Becher B., Prat A. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 2007, 13:1173-1175.
51. Zhou L., Chong M.M., Littman D.R. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009, 30:646-655.
52. Esser C., Rannug A., Stockinger B. The aryl hydrocarbon receptor in immunity. Trends Immunol. 2009, 30:447-454.
53. Dumoutier L., Van Roost E., Ameye G., Michaux L., Renauld J.C. IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun. 2000, 1:488-494.
54. Simons M., Trotter J. Wrapping it up: the cell biology of myelination. Curr. Opin. Neurobiol. 2007, 17:533-540.
55. Luther S.A., Cyster J.G. Chemokines as regulators of T cell differentiation. Nat. Immunol. 2001, 2:102-107.
56. Haas W., Pereira P., Tonegawa S. Gamma/delta cells. Annu. Rev. Immunol. 1993, 11:637-685.
57. Sobel R.A., Kuchroo V.K. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. J. Immunol. 1992, 149:1444-1451.
58. Hvas J., Oksenberg J.R., Fernando R., Steinman L., Bernard C.C. Gamma delta T cell receptor repertoire in brain lesions of patients with multiple sclerosis. J. Neuroimmunol. 1993, 46:225-234.
59. Olive C. Gamma delta T cell receptor variable region usage during the development of experimental allergic encephalomyelitis. J. Neuroimmunol. 1995, 62:1-7.
60. Shimonkevitz R., Colburn C., Burnham J.A., Murray R.S., Kotzin B.L. Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:923-927.
61. Chien Y.H., Konigshofer Y. Antigen recognition by gammadelta T cells. Immunol. Rev. 2007, 215:46-58.
62. Spada F.M., Grant E.P., Peters P.J., Sugita M., Melian A., Leslie D.S., Lee H.K., van Donselaar E., Hanson D.A., Krensky A.M., Majdic O., Porcelli S.A., Morita C.T., Brenner M.B. Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J. Exp. Med. 2000, 191:937-948.
63. van Noort J.M., van Sechel A.C., Bajramovic J.J., el Ouagmiri M., Polman C.H., Lassmann H., Ravid R. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature 1995, 375:798-801.
64. Vanderlugt C.L., Miller S.D. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2002, 2:85-95.
65. McMahon E.J., Bailey S.L., Castenada C.V., Waldner H., Miller S.D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 2005, 11:335-339.
66. Steinman L. New targets for treatment of multiple sclerosis. J. Neurol. Sci. 2008, 274:1-4.